Costa Carlos
SEC insider (Form 3/4/5 filer). CIK 0001939167. Chief People Officer at Foghorn Therapeutics Inc. (FHTX). 12 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in WATERTOWN, MA.
Companies Costa Carlos has filed insider reports for
- Foghorn Therapeutics Inc. (FHTX): Officer, Chief People Officer
Costa Carlos
CIK: 0001939167
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Foghorn Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jan 30, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock option (right to buy)
230K shares at avg. $5.71- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
115K shares at avg. $4.37- - Sep 23, 2024FHTX
Foghorn Therapeutics Inc.
ExerciseDirect857 shares at avg. $3.72$3K - Sep 23, 2024FHTX
Foghorn Therapeutics Inc.
SaleDirect857 shares at avg. $10.17$9K - Sep 20, 2024FHTX
Foghorn Therapeutics Inc.
ExerciseDirect35.8K shares at avg. $3.72$133K - Sep 20, 2024FHTX
Foghorn Therapeutics Inc.
SaleDirect35.8K shares at avg. $10.04$359K - Sep 18, 2024FHTX
Foghorn Therapeutics Inc.
SaleDirect11.6K shares at avg. $10.05$116K - Sep 18, 2024FHTX
Foghorn Therapeutics Inc.
ExerciseDirect11.6K shares at avg. $3.72$43K - Sep 17, 2024FHTX
Foghorn Therapeutics Inc.
ExerciseDirect10.3K shares at avg. $3.72$38K - Sep 17, 2024FHTX
Foghorn Therapeutics Inc.
SaleDirect10.3K shares at avg. $10.04$103K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 30, 2026 | FHTX Foghorn Therapeutics Inc. | Award Stock option (right to buy) | 230,000 | $5.71 | - | Direct |
| Jan 22, 2025 | FHTX Foghorn Therapeutics Inc. | Award Stock Option (right to buy) | 115,000 | $4.37 | - | Direct |
| Sep 23, 2024 | FHTX Foghorn Therapeutics Inc. | Exercise | 857 | $3.72 | $3,188 | Direct |
| Sep 23, 2024 | FHTX Foghorn Therapeutics Inc. | Sale | 857 | $10.17 | $8,716 | Direct |
| Sep 20, 2024 | FHTX Foghorn Therapeutics Inc. | Exercise | 35,756 | $3.72 | $133,012 | Direct |
| Sep 20, 2024 | FHTX Foghorn Therapeutics Inc. | Sale | 35,756 | $10.04 | $358,990 | Direct |
| Sep 18, 2024 | FHTX Foghorn Therapeutics Inc. | Sale | 11,574 | $10.05 | $116,319 | Direct |
| Sep 18, 2024 | FHTX Foghorn Therapeutics Inc. | Exercise | 11,574 | $3.72 | $43,055 | Direct |
| Sep 17, 2024 | FHTX Foghorn Therapeutics Inc. | Exercise | 10,272 | $3.72 | $38,212 | Direct |
| Sep 17, 2024 | FHTX Foghorn Therapeutics Inc. | Sale | 10,272 | $10.04 | $103,131 | Direct |
1-10 of 12 transactions